文献速递湿疹皮炎与荨麻疹

特应性皮炎瘙痒强度量表的评估:差异测量特性及与相关细胞因子的关联

Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines.
PubMed 文献 · J Invest Dermatol · 2026-04-20

所有量表反应性相当,但数值评定量表评分持续高于视觉模拟量表。巨噬细胞衍生趋化因子、CCL26、B细胞激活因子和IL-2R水平治疗后显著降低,并与全部或部分瘙痒及生活质量评分相关。

要点

  • 所有经验证瘙痒强度量表反应性相当,均适用于常规临床使用。
  • 数值评定量表评分持续高于视觉模拟量表,建议固定使用同一种工具。
  • 巨噬细胞衍生趋化因子和B细胞激活因子与所有瘙痒及生活质量评分相关。

核心结论

  • 所有经验证瘙痒强度量表均适用于常规临床使用,但建议坚持使用同一种工具。
  • 细胞因子水平与瘙痒量表的相关性提示其可作为特应性皮炎疾病负担的潜在标志物。

研究设计与样本

  • 在初始评估和治疗后,使用多种评估工具评价瘙痒强度和生活质量,并采集外周血进行细胞因子谱分析。

主要发现

  • 所有瘙痒强度量表均表现出相当的反应性,与其维度无关。
  • 数值评定量表持续产生比视觉模拟量表更高的评分。
  • 巨噬细胞衍生趋化因子、CCL26、B细胞激活因子和IL-2R水平在治疗后显著降低。
  • 巨噬细胞衍生趋化因子和B细胞激活因子与所有瘙痒强度及生活质量评分相关,CCL26和IL-2R与部分评分相关。

临床怎么用

  • 临床中可选用任一经验证瘙痒强度量表,但应固定使用同一种工具以保持数据可比性。
  • 细胞因子水平可能作为评估特应性皮炎疾病负担的辅助标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Itch is the cardinal symptom contributing to patient burden in atopic dermatitis. Multiple validated itch scales are used in clinical trials, generating heterogeneous datasets. In addition, recent studies suggest an association between cytokine levels and disease severity in atopic dermatitis. This study aimed to compare the performance of different validated itch instruments and their relationship to blood cytokine profiles. Forty-nine adults with severe atopic dermatitis and severe itch were treated with 300 mg dupilumab for 16 weeks. At the initial assessment and after treatment, itch intensity and QOL were evaluated using various assessment tools. Peripheral blood samples were collected at both time points for cytokine profiling. All itch intensity scales demonstrated comparable responsiveness, irrespective of their dimension; however, the numerical rating scale consistently yielded higher scores than the visual analog scale. Macrophage-derived chemokine, CCL26, B-cell-activating factor, and IL-2R levels were significantly reduced after treatment and correlated with all (macrophage-derived chemokine and B-cell-activating factor) or subsets (CCL26 and IL-2R) of itch intensity and QOL scores. In conclusion, all validated itch intensity scales are suitable for routine clinical use; however, adhering to one instrument is recommended. The observed correlations between cytokine levels and itch scales suggest their potential as markers of disease burden in atopic dermatitis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Witte F, Wiegmann H, Teitge E, et al. Evaluation of itch intensity scales in atopic dermatitis: Differential measurement properties and associations with relevant cytokines. J Invest Dermatol. 2026. PMID: 42019909. doi:10.1016/j.jid.2026.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。